Dupixent Injection: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBFeb 8, 2024 · Dupixent (dupilumab) is a biologic that is given by subcutaneous (under the skin) injection which may be used to treat moderate-to-severe eczema, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis.
Dupixent (Dupilumab): Side Effects, Cost, and More - Healthline
WEBOct 12, 2023 · Learn about side effects, cost, and more of Dupixent (dupilumab). It’s a prescription drug that treats atopic dermatitis (a type of eczema) and other conditions.
Dupilumab - Wikipedia
WEBDupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis.
Dupixent: 7 things you should know - Drugs.com
WEBFeb 9, 2024 · Dupixent is a brand (trade) name for dupilumab which may be used to reduce inflammation associated with asthma, eczema, and some other conditions. Dupixent (dupilumab) blocks the inflammatory response by binding to the interleukin-4Rα subunit which is shared by the interleukin-4 (IL-4) and IL-13-receptor complexes.
Frequently Asked Questions About DUPIXENT® (dupilumab)
WEBFind answers to frequently asked questions about DUPIXENT® (dupilumab), a prescription medicine FDA-approved to treat five conditions. Including how to administer DUPIXENT®, common side effects, and results seen in DUPIXENT® clinical trials. Serious side effects can occur. Please see Important Safety Information and Patient Information on ...
Description and Brand Names - Mayo Clinic
WEBDupixent; Descriptions. Dupilumab injection is used alone or in combination with other medicines (eg, topical corticosteroids) to treat moderate to severe atopic dermatitis in patients who have been treated with topical medicines that did not work well or who cannot use topical treatment.
DUPIXENT® (dupilumab) For Eosinophilic Esophagitis
WEBDUPIXENT® (dupilumab) is a prescription medicine used to treat people aged 6 years and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical corticosteroids.
Dupixent (Dupilumab Injection): Side Effects, Uses, Dosage ... - RxList
WEBAug 8, 2024 · Dupixent (dupilumab) injection is aninterleukin-4 receptor alpha- antagonist indicated for the treatment of patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable; as an add-on maintenance treatment of …
Eosinophilic Esophagitis Treatment With Dupixent - WebMD
WEBIf you or someone you know has eosinophilic esophagitis, you may have heard about Dupixent. In 2022, Dupixent became the first medicine to be approved for treating eosinophilic esophagitis.
FDA Approves Dupixent® (dupilumab) as First Treatment for …
WEBRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) 300 mg weekly to treat patients with eosinophilic esophagitis (EoE) aged 12 years and older, weighing at least 40 kg.